ReviewInflammopharmacology2022
A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19.
Gomaa Mostafa-Hedeab et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled ittrialcites it